Committee Testimony and Witness Signup
SB0200 - Public Health - Prescription Drug Monitoring Program - Naloxone Medication Data
Finance 1/27/2022 2:00:00 PM
Health and Government Operations 3/30/2022 1:30:00 PM
As of: 11/23/2024 7:25:33 PM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| Chair, Finance Committee, Chair, Finance Committee | FAV |
In Person - Oral Testimony |
FIN | |
| Gribble, Anna | Maryland Department of Health | FAV |
In Person - Oral Testimony |
FIN |
| Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - SB 200 FAV - Naloxone PDMP.pdf | FIN |
| Shek, Heather | Maryland Department of Health | FAV |
In Person - Oral Testimony 2 - SB 200 - FIN - MDH - LOS.pdf |
FIN |
| Doherty, Daniel | FAV | No Testimony | FIN | |
| Kasemeyer, Pam | FAV | SB0200_FAV_MedChi, MDACEP_PDMP - Naloxone Medicati | FIN | |
| Testimony, All | N/A | Merged Testimony as of 1-25-2022 at 306 PM | FIN | |
| Chair, Finance Committee, Chair, Finance Committee | FAV |
In Person - Oral Testimony |
HGO | |
| Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - SB 200 FAV - Naloxone PDMP - House.pdf | HGO |
| Gribble, Anna | Maryland Department of Health | FAV |
In Person - Oral Testimony |
HGO |
| Kasemeyer, Pam | FAV | SB0200 - House_FAV_MedChi, MDACEP_PDMP - Naloxone | HGO | |
| Shek, Heather | Maryland Department of Health | FAV | 8 - X - SB 200 - HGO - MDH - LOSAA.docx.pdf | HGO |
| Duffy, Suzanne | Concerned Citizen | UNF | No Testimony | HGO |